{
    "code": "02021644",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021644",
    "time": "2020-11-27 06:12:21",
    "許可證字號": "衛署藥輸字第021644號",
    "註銷狀態": "已註銷",
    "註銷日期": "109\/10\/08",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "",
    "有效日期": "111\/04\/17",
    "發證日期": "86\/04\/17",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202164402",
    "中文品名": "心寧美持續性藥效錠",
    "英文品名": "SINEMET CR 50\/200 TABLETS",
    "適應症": "．特發性帕金森氏症。．腦炎後之帕金森氏徵候群。．症狀性帕金森氏徵候群（一氧化碳或錳中毒）。．正服用含有ＰＹＲＩＤＯＸＩＮＥ維他命製劑之帕金森氏症或帕金森氏徵候群的病人。可降低先前曾以levodopa\/decarboxylase抑制劑之複方製劑或使用levodopa單方製劑治療的病人之無反應期，這些病人的運動功能波動特徵在藥效末期時有惡化(Wearing off)現象，尖峰劑量之運動困難，運動不能或短期運動失調之類似現象。",
    "劑型": "110錠劑",
    "包裝": "4-1000粒瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "LEVODOPA, CARBIDOPA",
    "限制項目": "02輸　入",
    "申請商名稱": "0929301100  美商默沙東藥廠股份有限公司台灣分公司",
    "申請商地址": "台北市信義區信義路五段106號12樓",
    "主製造廠": [
        {
            "製造廠名稱": "FUS0128000  MYLAN PHARM, INC.",
            "製造廠廠址": "781 CHESTNUT RIDGE ROAD, MORGANTOWN, WEST VIRGINIA 26505",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FNL0016000  MERCK SHARP &amp; DOHME B.V.",
            "製造廠廠址": "WAARDERWEG 39,2031 BN,HAARLEM,THE NETHERLANDS",
            "製造廠公司地址": "",
            "製造廠國別": "NETHERLANDS",
            "製程": "包裝及分裝"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208002900",
            "成分名稱": "LEVODOPA",
            "含量描述": "",
            "含量": "200.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2408000400",
            "成分名稱": "CARBIDOPA",
            "含量描述": "as equivqlent to Carbidopa Anhydrous 50 mg",
            "含量": "54.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "淡紅橙",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "橢圓形",
        "標記一": "SINEMET,CR",
        "標記二": "521"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "02021644.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021644&Seq=431&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "SINEMET CR_50-200_Leaflet_ver082013 (Eng)-104-09-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021644&Seq=007&Type=9"
        },
        {
            "title": "Sinemet CR 50 200 Tablets Label-104-08-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021644&Seq=002&Type=8"
        }
    ]
}